amikacin has been researched along with colistin in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (7.41) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (11.11) | 29.6817 |
| 2010's | 40 (49.38) | 24.3611 |
| 2020's | 26 (32.10) | 2.80 |
| Authors | Studies |
|---|---|
| Hoogkamp-Korstanje, JA; Westerdaal, NA | 1 |
| Bint, AJ; Speller, DC; Stephens, M | 1 |
| Gisselbrecht, C; Marty, M; Samson-Lepors, MJ | 1 |
| Kobayashi, Y | 1 |
| Cox, HU; Luther, DG | 1 |
| Belohradsky, BH; Marget, W; Roos, R | 1 |
| Ferranti, S; Menichetti, F; Messina, F; Tascini, C | 1 |
| Fulnecky, EJ; Kanawati, L; Scheld, WM; Shoham, S; Wright, D | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Cunha, BA | 1 |
| Benslama, A; Charra, B; Hachimi, A; Motaouakkil, S | 1 |
| Ciznár, I; Hostacká, A | 1 |
| Barnini, S; Barra, D; Batoni, G; Brancatisano, FL; Campa, M; Capria, AL; Di Luca, M; Esin, S; Maisetta, G; Mangoni, ML; Pichierri, G | 1 |
| Fukui, Y; Kamiya, A; Masuda, Y; Oie, S; Yamamoto, M | 1 |
| Boucher, BA; Croce, MA; Czosnowski, QA; Fabian, TC; Magnotti, LJ; Swanson, JM; Wood, GC | 1 |
| Bozkurt-Güzel, C; Gerçeker, AA | 1 |
| Bedenic, B; Bosnjak, Z; Colinon-Dupuich, C; Cournoyer, B; Orhanovic, S; Plecko, V; Rossolini, GM; Sardelic, S | 1 |
| Fiegel, J; Sommerfeld Ross, S | 1 |
| Budak, A; Paluchowska, P; Skałkowska, M; Spelak, A | 1 |
| Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M | 1 |
| Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L | 1 |
| Cunningham, KC; Greathouse, KM; Nevrekar, S; Panos, NG | 1 |
| Barberi, G; Cascio, A; Di Bernardo, F; Giordano, S; Iaria, C; Mezzatesta, ML; Odierna, A; Stefani, S | 1 |
| Goss, CH; Quon, BS; Ramsey, BW | 1 |
| Fiel, SB | 1 |
| Barba-Miramontes, MJ; Bou, G; Feal-Cortizas, B; Fernández-Trisac, JL; Gutiérrez-Urbón, JM; Suárez-Lorenzo, JM | 1 |
| Eksi, F; Nazli, E; Zer, Y | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Boiano, JM; Steege, AL; Sweeney, MH; Tsai, RJ | 1 |
| Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
| Beaudoin, T; LiPuma, JJ; Tom, SK; Waters, V; Yau, YC | 1 |
| Chen, CC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Lai, CC; Tang, HJ; Toh, HS; Weng, TC; Yu, WL; Zhang, CC | 1 |
| de Jonge, BL; Karlowsky, JA; Kazmierczak, KM; Nichols, WW; Sahm, DF | 1 |
| Berra, L; Klompas, M; Zhang, C | 1 |
| Glikman, D; Hoffmann, Y; Kassem, DF; Ocampo, S; Salomon, L; Shahar, N; Zonis, Z | 1 |
| Costa, SF; de Castro Lima, VA; de Maio Carrillho, CM; de Oliveira, LM; Gaudereto, JJ; Levin, AS; Martins, RC; Perozin, JS; Urbano, MR | 1 |
| Alexandropoulos, P; Chantziara, V; Chinou, E; Georgiou, S; Lagiou, F; Micha, G; Michaloudis, G; Tsimogianni, A; Vassi, A | 1 |
| Coenye, T; Crabbé, A; Davis, R; De La Fuente-Nùñez, C; Hancock, RE; Ledesma, MA; Liu, Y; Matthijs, N; Nickerson, CA; Rigole, P; Sarker, S; Van Houdt, R | 1 |
| Gao, L; Li, Y; Lyu, Y | 1 |
| Feng, Y; Liao, XP; Liu, YH; Sun, J; Tao, MT; Yang, RS; Zhou, YF | 1 |
| Hu, B; Li, JG; Liu, C; Peng, ZY; Zhang, YT; Zhou, H; Zhou, Q | 1 |
| Borgatta, B; Gattarello, S; Imbiscuso, AT; Larrosa, MN; Lujàn, M; Mazo, CA; Rello, J | 1 |
| Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A | 1 |
| Bail, L; da Silva Nogueira, K; Dalmolin, TV; Ito, CAS; Martins, AF; Martins, AS; Rocha, JLL; Serio, AW; Tuon, FF | 1 |
| Chatsuwan, T; Singkham-In, U | 1 |
| Coenye, T; Crabbé, A; Esteban, J; Mahíllo-Fernández, I; Ostyn, L; Peremarch, CP; Rigauts, C; Rodríguez-Sevilla, G; Vandeplassche, E | 1 |
| Arnaout, HH; Elshimy, AAA; Mostafa, MS; Nasr, AM | 1 |
| Britton, WJ; Chan, HK; Chang, RYK; Kutter, E; Lin, Y; Morales, S | 1 |
| Fernández Esgueva, M; Ferrer Cerón, I; García-Lechuz Moya, JM; López-Calleja, AI; Morilla Morales, E; Nuñez Medina, R; Rezusta López, A; Sahagún Pareja, J; Viñuelas Bayon, J | 1 |
| Aires, CAM; Asensi, MD; Carvalho-Assef, APD; Conceição-Neto, OC; da Silva, IR; de Oliveira Santos, IC; Ferreira Pereira, N; Moreno Senna, JP; Rocha-de-Souza, CM | 1 |
| Chung, ES; Ko, KS | 1 |
| Buitinck, S; Haak, EAF; Jansen, R; Nahar, J; van der Voort, PHJ | 1 |
| Çağ, Y; Can, F; Ergonul, O; Hacıseyitoğlu, D; Işık, ME; Menekşe, Ş; Şahin, S | 1 |
| Barros, M; Cunha, MS; Garrido, R; Tavares, A | 1 |
| Fu, Y; Guo, Y; Li, C; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, J; Zhao, Y | 1 |
| Baek, MS; Chung, ES; Jung, DS; Ko, KS | 1 |
| Antonelli, A; Cantón, R; Coppi, M; de Vogel, C; Gijón, D; Giske, CG; Hasan, B; Maruri, A; Rossolini, GM; Tellapragada, C; van Wamel, W; Verbon, A | 1 |
| Ko, WC; Stone, GG | 1 |
| Costa, SF; Espinoza, EPS; Gaudereto, JJ; Guimarães, T; Leite, GC; Levin, AS; Martins, RCR; Neto, LVP; Rossi, F; Villas Boa Prado, G | 1 |
| Almirante, B; Basas, J; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Hernandez, RM; Igartua, M; Palau, M; Pastor, M; Vairo, C | 1 |
| Alves, LC; Brayner, FA; Cavalcanti, CLB; da Rocha, DAM; da Silva, EM; Freitas, CF; Lima, FCG; Oliveira-Júnior, JB; Sandes, JM; Veras, DL | 1 |
| Alaminos, M; Bermejo-Casares, F; Campos, F; Carriel, V; Chato-Astrain, I; Chato-Astrain, J; Gainza, G; García-García, ÓD; Garzón, I; Oruezabal, RI; Ponce-Polo, Á; Sánchez-Porras, D; Vairo, C; Villar-Vidal, M; Villullas, S | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Hakamifard, A; Naji Esfahani, SS; Shafiee, F; Soltani, R | 1 |
| Piérard, D; Stone, GG | 1 |
| Baldissera, GS; Mathos, D; Rigatto, MH; Rodrigues, D; Sartori, A; Zavascki, AP | 1 |
| Honda, A; Ikeda, M; Kurokawa, M; Maki, H; Moriya, K; Sato, M; Toyama, K; Yamaguchi, R | 1 |
| Feng, H; He, L; Wu, H; Xu, P; Zhang, H | 1 |
| Bai, Y; Cui, J; Wang, F; Yang, X; Zhou, Q | 1 |
| Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
| Atac, N; Baskurt, D; Berkkan, M; Can, F; Dogan, O; Guler, OU; Kilicoglu, BK; Ozer, B; Sever, E; Vatansever, C | 1 |
| Blondeau, J; Lucaßen, K; Seifert, H; Utt, EA | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Antonelli, A; Cantón, R; Coppi, M; de Vogel, C; Frimodt-Møller, N; Gijón, D; Giske, CG; Hasan, B; Kragh, KN; Maruri, A; Morecchiato, F; Rossolini, GM; Tellapragada, C; van Wamel, W; Verbon, A | 1 |
| Cömert, B; Ergan, B; Ergün, B; Esenkaya, F; Gökmen, AN; Hanci, V; Heybeli, C; Küçük, M; Uzun, Ö; Yakar, MN | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Igartua, M; Maria Hernandez, R; Vairo, C; Villar Vidal, M; Villullas, S | 1 |
| Brink, A; Kamat, S; Kiratisin, P; Lin, S; Mohamed, N; Quintana, A; Rodríguez-Zulueta, AP; Su, M; Valdez, RR; Yang, Q | 1 |
| Bayatinejad, G; Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Salehi, M | 1 |
| Alves, LC; Bezerra Cavalcanti, CL; Brayner, FA; da Silva, EM; de Araújo, AR; de Freitas, CF; de Lima, FCG; do Nascimento, AV; Oliveira Júnior, JB; Sandes, JM; Veras, DL | 1 |
8 review(s) available for amikacin and colistin
| Article | Year |
|---|---|
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited.
Topics: Amikacin; Cell Membrane; Colistin; Doxycycline; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Minocycline; Nitrofurantoin; Polymyxin B; Staphylococcal Infections; Urinary Tract Infections | 2006 |
Inhaled antibiotics for lower airway infections.
Topics: Administration, Inhalation; Amikacin; Amphotericin B; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Colistin; Cystic Fibrosis; Gentamicins; Humans; Nebulizers and Vaporizers; Respiratory Tract Infections; Tobramycin | 2014 |
Aerosolized antibiotics in cystic fibrosis: an update.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Should Aerosolized Antibiotics Be Used to Treat Ventilator-Associated Pneumonia?
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Colistin; Humans; Pneumonia, Ventilator-Associated | 2016 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Colistin; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Humans; Liposomes; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Wound Infection | 2023 |
2 trial(s) available for amikacin and colistin
| Article | Year |
|---|---|
Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
Topics: Administration, Inhalation; Aged; Amikacin; Anti-Bacterial Agents; Colistin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated | 2017 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
72 other study(ies) available for amikacin and colistin
| Article | Year |
|---|---|
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Topics: Amikacin; Aminoglycosides; Ampicillin; Carbenicillin; Cephalothin; Child; Colistin; Cystic Fibrosis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Sputum; Tobramycin | 1979 |
Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
Topics: Aged; Amikacin; Colistin; Cross Infection; Disease Outbreaks; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Urinary Tract Infections | 1977 |
[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
Topics: Agranulocytosis; Amikacin; Colistin; Drug Therapy, Combination; Fever; Humans; Kanamycin; Neutropenia; Sulfamethoxazole; Trimethoprim | 1979 |
Effect of combined use of antibiotics against Pseudomonas aeruginosa in vitro.
Topics: Amikacin; Colistin; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Kanamycin; Pseudomonas aeruginosa | 1976 |
Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Colistin; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Colistin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Pseudomonas Infections; Rifampin | 2000 |
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Infusions, Intravenous; Injections, Spinal; Male; Meningitis, Bacterial; Middle Aged; Treatment Failure | 2005 |
[Intrathecal use of amikacin and colistin].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Amikacin; Brain Ischemia; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocephalus; Injections, Spinal; Male; Meningitis, Bacterial; Pseudomonas Infections; Shock, Septic; Surgical Wound Infection; Ventriculostomy | 2008 |
[Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Catheterization; Colistin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 2008 |
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Amphibian Proteins; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ceftazidime; Colistin; Drug Synergism; Humans; Kinetics; Levofloxacin; Microbial Viability; Ofloxacin; Peptide Fragments; Rana esculenta; Serum; Stenotrophomonas maltophilia | 2009 |
In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ceftazidime; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Adult; Aerosols; Amikacin; Anti-Bacterial Agents; APACHE; Colistin; Critical Illness; Drug Resistance, Multiple; Female; Glasgow Coma Scale; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Tobramycin; Treatment Outcome | 2009 |
Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia.
Topics: Amikacin; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Croatia; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping | 2012 |
Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Citrates; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Polymyxin B; Pseudomonas aeruginosa; Sodium Citrate; Succinic Acid | 2012 |
[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
Topics: Acinetobacter baumannii; Amikacin; Anesthesia Department, Hospital; Blood; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Environmental Monitoring; Epidemiological Monitoring; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Respiratory System; Species Specificity; Urine; Wounds and Injuries | 2012 |
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine | 2012 |
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline | 2013 |
Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cerebral Ventriculitis; Colistin; Female; Gentamicins; Humans; Infusions, Intraventricular; Klebsiella Infections; Klebsiella pneumoniae | 2014 |
Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cerebral Ventriculitis; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Teicoplanin; Treatment Outcome | 2014 |
Failure of a 5 day course of selective digestive decontamination solution in rectal decolonization of ESBL-producing Klebsiella pneumoniae in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Drug Administration Schedule; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Rectum; Treatment Failure | 2015 |
In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.
Topics: Adult; Aerosols; Amikacin; Anti-Infective Agents; Colistin; Female; Guideline Adherence; Health Personnel; Humans; Male; Middle Aged; National Institute for Occupational Safety and Health, U.S.; Occupational Exposure; Occupational Health; Pentamidine; Respiratory Therapy; Surveys and Questionnaires; Tobramycin; United States | 2015 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
Topics: Achromobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Biofilms; Colistin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Plankton; Tobramycin | 2016 |
Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; DNA, Bacterial; Doxycycline; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Genotype; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2019 |
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).
Topics: Africa; Amikacin; Anti-Bacterial Agents; Asia; Azabicyclo Compounds; beta-Lactams; Ceftazidime; Colistin; Drug Combinations; Humans; Latin America; Meropenem; Microbial Sensitivity Tests; Middle East; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2016 |
Multidrug-Resistant Pathogens in Hospitalized Syrian Children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Armed Conflicts; Bacterial Infections; Child; Child, Preschool; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; Infant; Infant, Newborn; Israel; Male; Meropenem; Multiple Trauma; Syria; Thienamycins | 2017 |
Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia; Prospective Studies; Soft Tissue Infections; Tigecycline; Urinary Tract Infections | 2017 |
Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Central Nervous System Infections; Colistin; Humans; Injections, Intraventricular; Injections, Spinal; Intensive Care Units; Neurosurgical Procedures; Retrospective Studies; Vancomycin | 2017 |
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.
Topics: A549 Cells; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cattle; Cell Culture Techniques; Colistin; Drug Synergism; Fetus; Gentamicins; Humans; Lung; Microbial Sensitivity Tests; Models, Biological; Oligopeptides; Pseudomonas aeruginosa; Serum; Tight Junctions; Tobramycin | 2017 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Mice; Microbial Sensitivity Tests | 2017 |
The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Ventilators, Mechanical | 2017 |
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenem-Resistant Enterobacteriaceae; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins | 2018 |
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand | 2018 |
Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ceftazidime; Cell Culture Techniques; Clarithromycin; Colistin; Drug Resistance, Bacterial; Epithelial Cells; Host-Pathogen Interactions; Humans; Lung; Microbial Interactions; Microbial Sensitivity Tests; Mycobacterium abscessus; Pseudomonas aeruginosa; Species Specificity | 2018 |
The effect of exposure to sub-inhibitory concentrations of hypochlorite and quaternary ammonium compounds on antimicrobial susceptibility of Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Infective Agents; Ceftazidime; Colistin; Disinfectants; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quaternary Ammonium Compounds; Sodium Hypochlorite | 2018 |
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Phages; Tobramycin | 2018 |
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam | 2019 |
Distribution of Clinical NDM-1-Producing Gram-Negative Bacteria in Brazil.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Brazil; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Tertiary Care Centers | 2019 |
Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adenosine Triphosphate; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Membrane Potentials; Microbial Sensitivity Tests; Microbial Viability | 2019 |
Use of enteral amikacin to eliminate carriership with multidrug resistant Enterobacteriaceae.
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Cross-Sectional Studies; Enterobacteriaceae; Prevalence | 2019 |
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tigecycline; Young Adult | 2019 |
Late-onset neonatal sepsis:
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Central Venous Catheters; Colistin; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Neonatal Sepsis; Parenteral Nutrition; Placenta; Pregnancy; Risk Factors | 2019 |
Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2019 |
Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2020 |
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Calorimetry; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Netherlands; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Spain; Sweden | 2020 |
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
Topics: Amikacin; Anti-Bacterial Agents; Asia; Australia; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2020 |
Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria.
Topics: Amikacin; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Microbial Sensitivity Tests; Microbial Viability | 2020 |
In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC).
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Colistin; Drug Carriers; Drug Resistance, Bacterial; Humans; Lipids; Nanostructures; Pseudomonas aeruginosa | 2020 |
Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Immunoglobulins, Intravenous; Meropenem; Microbial Sensitivity Tests | 2020 |
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Cell Proliferation; Cell Survival; Cells, Cultured; Colistin; Drug Carriers; Fibroblasts; Humans; Lipids; Nanostructures; Skin, Artificial; Tissue Engineering | 2020 |
In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Colistin; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Citrobacter koseri; Colistin; Drug Combinations; Enterobacteriaceae; Epidemiological Monitoring; Escherichia coli; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tigecycline | 2021 |
Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy | 2022 |
In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Tigecycline | 2021 |
Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline; Time Factors | 2021 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
Efficacy of Amikacin and Meropenem on Colistin-Induced
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Colistin; Gram-Negative Bacteria; Levofloxacin; Meropenem; Phenotype; Tigecycline | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis.
Topics: Acute Kidney Injury; Amikacin; Colistin; Critical Illness; Humans; Intensive Care Units; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
Antimicrobial Susceptibility Among Gram-Negative Isolates in Pediatric Patients in Latin America, Africa-Middle East, and Asia From 2016-2020 Compared to 2011-2015: Results From the ATLAS Surveillance Study.
Topics: Africa; Amikacin; Ascomycota; Asia; Child; Colistin; Escherichia coli; Humans; Latin America; Middle East | 2023 |
In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Colistin; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated | 2023 |
In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Immunoglobulins, Intravenous; Meropenem; Microbial Sensitivity Tests | 2023 |